Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.

Amgen announced the phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its primary endpoint of overall survival (OS) at a pre-specified interim ...

FGFR2b overexpression was defined as 2+/3+ staining in ≥10% of tumor cells by ... plus chemotherapy were reduced visual acuity, punctate keratitis, anaemia, neutropenia, nausea, corneal epithelium ...

Treatment differences on study outcomes (eg, fluorescein staining, dry eye disease symptoms) for perfluorohexyloctane versus hypotonic (0.6%) saline were generally consistent with findings of this ...

Mechanisms of Corneal Allergic Reaction: New Options for Treatment Andrea Leonardi; Anthony Hall Disclosures Expert Rev Ophthalmol. 2010;5 (4):545-556. 0 ...

Schultz et al. found corneal epithelial lesions, ranging from superficial punctate keratitis to full-thickness breaks, in up to two-thirds of their patients. [7] This same group also reported a ...

A medical examiner hired by Karen Read's defense pushed back on the prosecution's theory of the case, giving key testimony as Read's retrial winds down.

Dove, Kiehl's, Gilette: We sweat it out for you to fin the best antiperspirants that won't stain your shirts while keeping you dry.

A sodium hyaluronate-containing gel and eye drop have significant antioxidant, anti-inflammatory, and osmo-protective effects on human corneal epithelial cells under dry eye disease (DED) -related ...

Aliasger Salem University of Iowa researchers have been awarded funding from the National Institutes of Health to explore new ways to prevent or reduce vision loss caused by a degenerative eye disease ...